Search Prime Grants

UG3NS127386

Cooperative Agreement

Overview

Grant Description
Optimization of EP2 antagonists for post-seizure cognitive deficits.
Awardee
Emory University
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders
Awarding / Funding Agency
National Institute of Neurological Disorders and Stroke (NNDS) [HHS - NIH]
Place of Performance
Atlanta, Georgia 30322 United States
Geographic Scope
Single Zip Code
Related Opportunity
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) (PAR-20-122)
Analysis Notes
Amendment Since initial award the total obligations have decreased 9% from $677,532 to $613,838.
Emory University was awarded Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits Cooperative Agreement UG3NS127386 worth $613,838 from the National Institute of Neurological Disorders and Stroke in May 2022 with work to be completed primarily in Atlanta Georgia United States. The grant has a duration of 1 year and was awarded through assistance program 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders. The Cooperative Agreement was awarded through grant opportunity Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional).

Status
(Complete)

Last Modified 11/9/23

Period of Performance
5/1/22
Start Date
4/30/23
End Date
100% Complete

Funding Split
$613.8K
Federal Obligation
$0.0
Non-Federal Obligation
$613.8K
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to UG3NS127386

Transaction History

Modifications to UG3NS127386

Additional Detail

Award ID FAIN
UG3NS127386
SAI Number
UG3NS127386-3751912179
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NQ00 NIH NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Funding Office
75NQ00 NIH NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Awardee UEI
S352L5PJLMP8
Awardee CAGE
2K291
Performance District
GA-05
Senators
Jon Ossoff
Raphael Warnock

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Health and Human Services (075-0886) Health research and training Grants, subsidies, and contributions (41.0) $677,532 100%
Modified: 11/9/23